Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: A Mendelian randomization study

International Journal of Epidemiology

Volumn 44, Issue 2, 2015, Pages 551-565

  Nordestgaard, Ask Tybjærg ^a,c   Thomsen, Mette ^a,c   Nordestgaard, Børge Grønne ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Blood pressure; BMI; Coffee; Metabolic syndrome; Plasma cholesterol, plasma glucose; Type 2 diabetes

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; AHR PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COFFEE; CYP1A1 PROTEIN, HUMAN; CYP1A2 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

BODY CONDITION; BODY MASS; COFFEE; COHORT ANALYSIS; DISEASE INCIDENCE; GENETIC ANALYSIS; GENETIC VARIATION; META-ANALYSIS; METABOLISM; RISK ASSESSMENT; RISK FACTOR;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; AGED; BLOOD PRESSURE; DENMARK; DIABETES MELLITUS, TYPE 2; GENETIC POLYMORPHISM; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COFFEE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPID METABOLISM; MALE; MENDELIAN RANDOMIZATION ANALYSIS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ARYL HYDROCARBON; RISK FACTORS;

EID: 84936773598     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv083     Document Type: Article

References (37)

1. Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev. Food Sci Nutr 2011;51:363-73.
2. Nawrot P, Jordan S, Eastwood, J et al. Effects of caffeine on human health. Food Addit Contam 2003;20:1-30.
3. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891-904.
4. Huxley R, Lee CM, Barzi F et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009;169:2053-63.
5. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97-104.
6. Natella F, Scaccini C. Role of coffee in modulation of diabetes risk. Nutr Rev 2012;70:207-17.
7. Ding M, Bhupathiraju SN, Satija, A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014;129:643-59.
8. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 2014;53:25-38.
9. O'Keefe JH, Bhatti SK, Patil HR et al. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 2013;62:1043-51.
10. Hino A, Adachi H, Enomoto M et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007;76:383-89.
11. Grosso G, Stepaniak U, Micek A et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 2014, Nov 4. PMID: 25367317. [Epub ahead of print.].
12. Matsuura H, Mure K, Nishio N et al. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 2012;22:160-66.
13. Rebello SA, van Dam RM. Coffee consumption and cardiovascular health: getting to the heart of the matter. Curr Cardiol Rep 2013;15:403.
14. Davey Smith, G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
15. Rodenburg EM, Eijgelsheim M, Geleijnse JMet al. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. Am J Clin Nutr 2012;96:182-87.
16. Sulem P, Gudbjartsson, DF, Geller F et al. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet 2011;20:2071-77.
17. Cornelis MC, Monda KL, Yu K et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 2011;7:e1002033.
18. Frikke-Schmidt R, Nordestgaard BG, Stene MC et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008;299:2524-32.
19. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-39.
20. Zacho J, Tybjaerg-Hansen A, Jensen JS et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-908.
21. Morris AP, Voight BF, Teslovich TM et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-90.
22. Hermansen K, Bech BH, Dragsted LO et al. 2012. http://www.vidensraad.dk/sites/default/files/kaffe_sundhed_og_sygdom_0.pdf (10 May 2015, date last accessed).
23. Nordestgaard BG, Palmer TM, Benn M et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomization approach. PLoS Med 2012;9:e1001212.
24. Knowler WC, Fowler SE, Hamman RF et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-86.
25. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
26. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEngl J Med 2001;344:1343-50.
27. Imamura M, Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives. [Review.] Endocr J 2011;58: 723-39.
28. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci U S A 2010;1212: 59-77.
29. Ding M, Bhupathiraju SN, Chen, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response metaanalysis. Diabetes Care 2014;37:569-86.
30. Bhupathiraju SN, Pan A, Manson JE et al. Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women. Diabetologia 2014;57:1346-54.
31. Tunnicliffe JM, Shearer J. Coffee, glucoseand insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290-300.
32. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 2006;84:682-93.
33. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27: 1133-63.
34. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009;77:713-22.
35. Zhou SF, Wang B, Yang LP, Liu JP. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 2010;42:268-354.
36. McMahon G, Taylor AE, Davey Smith G, Munafo MR. Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption. PLoS One 2014; 9:e103448.
37. Sivertsen SH. Diabetes in Denmark. 2014. http://diabetes.dk/presse/diabetes-i-tal/diabetes-i-danmark.aspx (10 May 2015, date last accessed).